MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617093369 A) filed by Denali Therapeutics Inc. on July 31, 2026, for Compositions And Methods For Modulating Alpha-Synuclein Expression.
Inventors include Devos, Sarah L.; Barker, Scarlett; Thayer, Mai B.; Klar, Richard; Michel, Sven; Jaschinski, Frank; and Rothkirch, Larissa.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Provided herein are SNCA antisense oligonucleotides that are capable of modulating the expression of a SNCA target nucleic acid. Also provided herein are methods of use thereof.
Disclaimer: Curated by HT Syndication....